Safe Orthopaedics SA (ALSAF.PA)
- Previous Close
0.0026 - Open
0.0026 - Bid --
- Ask --
- Day's Range
0.0024 - 0.0026 - 52 Week Range
0.0024 - 2.4000 - Volume
511,782 - Avg. Volume
1,973,490 - Market Cap (intraday)
79,953 - Beta (5Y Monthly) 0.37
- PE Ratio (TTM)
-- - EPS (TTM)
-30.0000 - Earnings Date Jun 30, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Safe Orthopaedics SA, a medical technology company, engages in the design, manufacturing, and marketing of sterile implants and single-use sterile surgical instruments for the treatment of spinal surgery. The company's products portfolio includes SteriSpine PS, an all-round kit for the treatment of spinal fractures and degenerative pathologies, as well as essential kit for percutaneous treatment of spinal fractures; SteriSpine VA, a product platform for ready to use Kyphoplasty and Cement systems; SteriSpine LC, a ready to use instrumentation for lumbar cage portfolio, including Cedar and Elm; and SteriSpine CC, a ready to use instrumentation for cervical cage, such as Walnut. Safe Orthopaedics SA was founded in 2010 and is headquartered in Eragny-sur-Oise, France.
www.safeorthopaedics.comRecent News: ALSAF.PA
View MorePerformance Overview: ALSAF.PA
Trailing total returns as of 5/22/2025, which may include dividends or other distributions. Benchmark is CAC 40 (^FCHI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ALSAF.PA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ALSAF.PA
View MoreValuation Measures
Market Cap
74.24k
Enterprise Value
199.68M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.00
Price/Book (mrq)
--
Enterprise Value/Revenue
34.37
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-8.19%
Return on Equity (ttm)
--
Revenue (ttm)
5.81M
Net Income Avi to Common (ttm)
-205.44M
Diluted EPS (ttm)
-30.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
591k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-2.72M